Sunny Levine Comments on New SAMHSA Telehealth Proposal
January 10, 2023
Kaiser Health News
Foley & Lardner LLP Associate Sunny Levine is quoted in the Kaiser Health News article, “Behavioral Telehealth Loses Momentum Without a Regulatory Boost,” discussing the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) recent proposal to codify telehealth regulation on opioid treatment programs.
While this proposal only affects part of the sector and leaves unaddressed the process for individual providers to register to prescribe buprenorphine, Levine said the new rules “get us at least a little bit closer to where we need to go.”
This article also ran in CBS News.
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."